February 16, 2022 -- Thermo Fisher Scientific has launched new integrated commercial packaging and distribution services. Patheon Commercial Packaging Services for Cell and Gene Therapies is an end-to-end solution combining the good manufacturing practices (GMP) storage, serialization, ultracold and cryogenic packaging, and global distribution that developers need to support their logistics strategies.
The cell and gene therapy market is expected to reach a commercialization inflection point, with the U.S. Food and Drug Administration anticipating 10 to 20 new approvals per year through 2025. In launching these new therapies, cell and gene therapy developers require specific validated processes for their commercial logistics strategy from labeling to shipping.
Thermo Fisher's new services include regulatory-compliant serialization, deep expertise in commercial cold-chain and cryogenic storage and global distribution, transportation management, global infrastructure, and clinical to commercial scalability.
The new services complement the company's fully integrated development and manufacturing capabilities for cell and gene therapy, which include translational biology, process development, and GMP batch manufacturing services to help streamline the path from discovery to the clinic across the entire supply chain.